Literature DB >> 11524350

Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats.

S Ohmura1, M Kawada, T Ohta, K Yamamoto, T Kobayashi.   

Abstract

We compared the systemic toxicity of bupivacaine, levobupivacaine, and ropivacaine in anesthetized rats. We also compared the ability to resuscitate rats after lethal doses of these local anesthetics. Bupivacaine, levobupivacaine, or ropivacaine was infused at a rate of 2 mg. kg(-1). min(-1) while electrocardiogram, electroencephalogram, and arterial pressure were continuously monitored. When asystole was recorded, drug infusion was stopped and a resuscitation sequence was begun. Epinephrine 0.01 mg/kg was administered at 1-min intervals while external cardiac compressions were applied. Resuscitation was considered successful when a systolic arterial pressure > or =100 mm Hg was achieved within 5 min. The cumulative doses of levobupivacaine and ropivacaine that produced seizures were similar and were larger than those of bupivacaine. The cumulative doses of levobupivacaine that produced dysrhythmias and asystole were smaller than the corresponding doses of ropivacaine, but they were larger than those of bupivacaine. The number of successful resuscitations did not differ among groups. However, a smaller dose of epinephrine was required in the Ropivacaine group than in the other groups. We conclude that the systemic toxicity of levobupivacaine is intermediate between that of ropivacaine and bupivacaine when administered at the same rate and that ropivacaine-induced cardiac arrest appears to be more susceptible to treatment than that induced by bupivacaine or levobupivacaine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524350     DOI: 10.1097/00000539-200109000-00039

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  25 in total

Review 1.  [Toxicology of local anesthetics. Clinical, therapeutic and pathological mechanisms].

Authors:  W Zink; B M Graf
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

Review 2.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  [The toxicity of ropivacaine is dose, not concentration dependent].

Authors:  M Müller
Journal:  Anaesthesist       Date:  2005-08       Impact factor: 1.041

4.  Comparison of the effect of low-dose ropivacaine and lidocaine in intravenous regional anaesthesia : a randomised, double-blind clinical study.

Authors:  Zekiye Bigat; Bilge Karsli; Neval Boztug; Nihan Cete; Ertugrul Ertok
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 5.  Anaesthetic agents for advanced regional anaesthesia: a North American perspective.

Authors:  Chester C Buckenmaier; Lisa L Bleckner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

7.  Intraarticular levobupivacaine or bupivacaine administration decreases pain scores and provides a better recovery after total knee arthroplasty.

Authors:  Zuleyha Kazak Bengisun; E Aysu Salviz; Kamil Darcin; Hikmet Suer; Yesim Ates
Journal:  J Anesth       Date:  2010-06-23       Impact factor: 2.078

8.  Anatomical consideration of the anterior and lateral cutaneous nerves in the scalp.

Authors:  Seong Man Jeong; Kyung Jae Park; Shin Hyuk Kang; Hye Won Shin; Hyun Kim; Hoon Kap Lee; Yong Gu Chung
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

9.  Evaluation of the effects of ketamine on spinal anesthesia with levobupivacaine or ropivacaine.

Authors:  Yan Zhang; Hong Lin; Wen-Bo Yi
Journal:  Exp Ther Med       Date:  2016-08-10       Impact factor: 2.447

Review 10.  Pain management mini-series. Part I. A review of management of acute pain.

Authors:  Quinn Johnson; Robert R Borsheski; Joseph L Reeves-Viets
Journal:  Mo Med       Date:  2013 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.